Reaction

Pulmonary Sepsis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,428 reports · 47 co-occurring drugs

As of the last recalculation, Pulmonary Sepsis appears in 1,428 FAERS reports alongside 47 co-occurring drug terms. The strongest observed disproportionality signal is AMPHOTERICIN B (PRR 28.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Amphotericin B	24	28.4	28.4
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose	15	27.0	27.0
Azacitidine For	28	22.9	22.9
Azacitidine	42	21.2	21.3
Everolimus Tablets	21	18.5	18.5
Posaconazole Delayed-Release	13	17.4	17.4
Pitavastatin Calcium	11	15.8	15.8
Granisetron Hydrochloride	11	15.5	15.5
Granisetron	11	15.4	15.4
Thiotepa	10	15.4	15.4
Paricalcitol	14	14.6	14.6
Atovaquone	8	14.6	14.6
Meropenem	29	13.4	13.4
Posaconazole	14	12.7	12.7
Carfilzomib	24	12.6	12.6
Norepinephrine	9	12.3	12.4
Piperacillin Sodium,Tazobactam Sodium	21	11.7	11.7
Piperacillin And Tazobactam	10	11.5	11.5
Ipilimumab	33	11.4	11.4
Basiliximab	9	11.2	11.2
Daptomycin	7	11.1	11.1
Valganciclovir Hydrochloride Powder,	9	10.8	10.8
Daratumumab	29	10.8	10.8
Bendamustine Hcl	11	10.4	10.4
Midazolam	16	9.3	9.4
Nivolumab	59	9.2	9.2
Norepinephrine Bitartrate	9	9.2	9.2
Obinutuzumab	10	8.9	8.9
Pemetrexed	13	8.9	8.9
Insulin Glargine-Yfgn	13	8.7	8.7
Carboplatin	63	7.5	7.5
Polatuzumab Vedotin	5	7.5	7.5
Bleomycin Sulfate	5	7.1	7.1
Alirocumab	12	7.0	7.0
Venetoclax	29	7.0	7.0
Bortezomib	41	6.8	6.9
Paclitaxel	39	5.9	5.9
Pemetrexed Disodium	15	5.8	5.8
Dronedarone	4	5.7	5.7
Iohexol	3	5.3	5.3
Cetuximab	10	4.7	4.7
Atezolizumab	12	4.5	4.5
Axicabtagene Ciloleucel	3	4.4	4.4
Palivizumab	4	3.8	3.8
Pomalidomide	26	3.7	3.7
Lenalidomide	87	3.1	3.1
Tapentadol Hydrochloride	6	2.6	2.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.